These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3330253

  • 21. [Effect of lipanthyl on parameters of lipid metabolism in patients with primary hyperlipoproteinemia].
    Sznajd J, Magdoń M, Idzior B, Konarska R, Malczewska M, Czarnecka H.
    Przegl Lek; 1984; 41(2):217-21. PubMed ID: 6377392
    [No Abstract] [Full Text] [Related]

  • 22. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER, Sutherland WH, Temple Wa.
    N Z Med J; 1980 Nov 12; 92(671):345-9. PubMed ID: 6935550
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
    Sirtori CR, Franceschini G, Gianfranceschi G, Sirtori M, Montanari G, Tremoli E, Maderna P, Colli S, Zoppi F.
    J Lab Clin Med; 1987 Sep 12; 110(3):279-86. PubMed ID: 3475394
    [Abstract] [Full Text] [Related]

  • 25. Gemfibrozil, lipids, and coronary risk.
    Rifkind BM.
    N Engl J Med; 1987 Nov 12; 317(20):1279-81. PubMed ID: 3313042
    [No Abstract] [Full Text] [Related]

  • 26. Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure.
    Pasternack A, Vänttinen T, Solakivi T, Kuusi T, Korte T.
    Clin Nephrol; 1987 Apr 12; 27(4):163-8. PubMed ID: 3555908
    [Abstract] [Full Text] [Related]

  • 27. The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC).
    Børresen AL, Berg K, Dahlén G, Gillnäs T, Ericson C.
    Artery; 1981 Apr 12; 9(1):77-86. PubMed ID: 7018466
    [Abstract] [Full Text] [Related]

  • 28. [Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV].
    Sznajderman M.
    Przegl Lek; 1984 Apr 12; 41(7):493-9. PubMed ID: 6390536
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The Gemfibrozil Study.
    Manninen V.
    Acta Med Scand Suppl; 1985 Apr 12; 701():83-8. PubMed ID: 3907298
    [Abstract] [Full Text] [Related]

  • 33. Serum lipoprotein pattern after SAMe-treatment.
    Rini GB, Di Fede G, Rotolo G, Rizzo G, Mascellino MR, Affronti M, Delle Vedove G.
    Boll Soc Ital Biol Sper; 1987 Oct 31; 63(10):919-22. PubMed ID: 3447603
    [No Abstract] [Full Text] [Related]

  • 34. Gemfibrozil treatment and the relationship between HDL cholesterol and apoE distribution in cholesterol-fed rats.
    Krause BR, Newton RS.
    Atherosclerosis; 1986 Sep 31; 61(3):245-8. PubMed ID: 3464282
    [No Abstract] [Full Text] [Related]

  • 35. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
    Canzler H, Bojanovski D.
    Artery; 1980 Sep 31; 8(2):171-8. PubMed ID: 7458684
    [Abstract] [Full Text] [Related]

  • 36. [Correction of dyslipoproteinemia in middle-aged and elderly patients with atherosclerosis using Essentiale in combination with adebit].
    Korkushko OV, Bogatskaia LN, Kovalenko AN, Novikova SN, Kotko DN.
    Vrach Delo; 1989 Aug 31; (8):19-22. PubMed ID: 2588515
    [Abstract] [Full Text] [Related]

  • 37. Effects of gemfibrozil on serum lipids.
    Samuel P.
    Am J Med; 1983 May 23; 74(5A):23-7. PubMed ID: 6573843
    [Abstract] [Full Text] [Related]

  • 38. A comparison of different formulations and dosage administrations of gemfibrozil.
    Kovanen PT, Koskinen P, Manninen V.
    Am J Cardiol; 1986 May 30; 57(14):31G-34G. PubMed ID: 3459351
    [Abstract] [Full Text] [Related]

  • 39. Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study.
    Manninen V, Mälkönen M, Eisalo A, Virtamo J, Tuomilehto J, Kuusisto P.
    Acta Med Scand Suppl; 1982 May 30; 668():82-7. PubMed ID: 6762809
    [No Abstract] [Full Text] [Related]

  • 40. Nutritional & pharmacologic management of hyperlipoproteinemia.
    Pickering JE.
    Angiology; 1982 Sep 30; 33(9):577-80. PubMed ID: 6957154
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.